Graf Acquisition Partners IV LLC insider trades: NKGen Biotech (NKGN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Graf Acquisition Partners IV LLC reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | NKGN | ↑ Buy | 670 | $3.24 | $2K | Direct | Dec 5, 2023 (1d) |
| Nov 21, 2023 | NKGN | ↑ Buy | 23 | $2.93 | $67 | Direct | Nov 22, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Graf Acquisition Partners IV LLC's insider trades
Graf Acquisition Partners IV LLC is a 10% owner of NKGen Biotech (NKGN). Since Nov 21, 2023, it has reported 2 open-market purchases worth $2K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (5 filings), shares returned to the company (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NKGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.